Matthew S. Holt, Director, 10% Owner at Bellerophon Therapeutics, Inc. (BLPH), bought 1,530,310 shares at $12.00 ($12.8M) on 2015-02-19, disclosed to the SEC on 2015-02-23.
Open-market purchase of $12.8M BLPH by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 460,144 | $0 | 0.0% |
| 2 | $12.00 | 1,070,166 | $12.8M | 100.0% |
| Total | $8.39 avg | 1,530,310 | $12.8M | 100% |